Search

everythinglearnresearchcommunity

for

Search:↓

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

Particles around 100 nm can penetrate and stay in hair follicles without passing through healthy skin, making them safe for use in topical products and useful for targeted drug delivery.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Cosmetic treatments like bleaching and perming can greatly reduce opiate levels in hair, possibly leading to false-negative drug tests.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Photobiomodulation may help with hair growth and wound healing, but research is inconsistent and needs better quality studies.

Infrared light can trigger drug release from gold nanoparticle carriers in hair follicles.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

Curcumin can be effectively loaded into polystyrene nanoparticles, which are safe for human cells and more biocompatible with curcumin inside.

The drug combination significantly reduced epileptic drop attacks in patients.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

Finasteride breakdown products found in bile and urine, helps understand drug safety and effectiveness.

Improved tablets lead to faster, better drug absorption for hair loss treatment.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Ethosomal carriers effectively deliver hair loss drug into skin.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

The compound 16 from the Merremia peltata plant could potentially be a good treatment for hair loss (alopecia) due to its strong activity and favorable skin absorption.

The new nanocarriers improve how well water-insoluble drugs dissolve and allow for controlled drug release.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

AnnoPharma effectively identifies substances causing adverse drug reactions in medical abstracts.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Computational tools identified 29 drugs that could potentially target 19 genes involved in chemotherapy-induced hair loss, which could lead to more effective treatments.

New drug shows promise for better hair growth in baldness treatment.

Nanofiber scaffolds help wounds heal by delivering drugs directly to the injury site.

Microemulsions could improve skin drug delivery but face challenges like complex creation and potential toxicity.

3D bioprinting is useful for making tissues, testing drugs, and delivering drugs, but needs better materials, resolution, and scalability.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

New microneedles deliver drugs through the skin accurately and effectively.